Halozyme Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of HALO for the last quarter is 195.88 M USD, and it's 14.85% lower compared to the previous quarter. The net income of Q1 24 is 76.82 M USD.